You searched for side effects - Page 65 of 311

Evaluating the effectiveness of brentuximab vedotin and AVD chemotherapy combination in high-risk patients with advanced classical Hodgkin lymphoma

Posted by Medivizor on Feb 21, 2021 in Hodgkin's lymphoma | 0 comments

In a nutshell This study compared the long-term safety and effectiveness of ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) and brentuximab vedotin (Adcedris; A) + AVD (doxorubicin, vinblastine, and dacarbazine) chemotherapy combinations in high-risk patients with advanced classical Hodgkin lymphoma (cHL). The data showed that the A+AVD...

Adding S-1 to hormonal therapy in patients with ER+ HER2- breast cancer

Posted by Medivizor on Feb 21, 2021 in Breast cancer | 0 comments

In a nutshell This study investigated whether adding oral S-1 (Teysuno) to hormonal therapy improved outcomes in patients with estrogen receptor (ER)-positive and HER2-negative primary breast cancer (BC). The data showed that the combination of S-1 with hormonal therapy could be a potential treatment option for these patients. Some background...

Does anti-cancer therapy improve the outcomes of older patients with metastatic non-small cell lung cancer?

Posted by Medivizor on Feb 21, 2021 in Lung cancer | 0 comments

In a nutshell This article looked at whether anti-cancer treatments can improve the outcomes of older patients with metastatic (cancer that has spread to a new location) non-small cell lung cancer (mNSCLC). The authors found that outcomes were improved with anti-cancer therapies in these patients. Some background NSCLC is responsible...

Long-term follow-up after bortezomib, thalidomide, and dexamethasone treatment followed by double stem cell transplant in patients with multiple myeloma.

Posted by Medivizor on Feb 21, 2021 in Multiple Myeloma | 0 comments

In a nutshell This study compared long-term outcomes after treatment with bortezomib (Velcade), thalidomide (Thalomid), and dexamethasone (Ozurdex) or VTD compared to thalidomide and dexamethasone (TD) followed by double hematopoietic stem cell transplant (HSCT) in patients with newly diagnosed multiple myeloma (MM). The study found...

Long term outcomes of nilotinib versus imatinib in chronic phase chronic myeloid leukemia

Posted by Medivizor on Feb 21, 2021 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the long-term outcomes of nilotinib (Tasigna) versus imatinib (Gleevec) in patients with chronic-phase chronic myeloid leukemia (CP-CML). This study concluded that nilotinib provided good long-term outcomes for these patients. Some background CML results from a gene...

Is heart monitoring needed in patients with HER2-positive metastatic breast cancer using trastuzumab?

Posted by Medivizor on Feb 20, 2021 in Breast cancer | 0 comments

In a nutshell This article looked at the occurrence of heart-related side effects in patients with HER2-positive metastatic breast cancer (mBC) receiving trastuzumab (Herceptin). The authors found that non-smoking patients with a good heart function before receiving treatment have a low risk of heart toxicity (HT) after 4 years...

Dietary Supplement Warning, Again!

Posted by Kathleen Hoffman on Feb 19, 2021 in Blog |

Lots of people take dietary supplements. Unfortunately, they are not all that their producers claim. A previous post notified readers of FDA warnings to dietary supplement producers. Today another dietary supplement warning has come out and it is especially pertinent as so many of us are experiencing sadness and depression due to social distancing and the...

Controlling brain metastasis with localized radiotherapy.

Posted by Medivizor on Feb 17, 2021 in Melanoma | 0 comments

In a nutshell This study evaluated the impact of radiotherapy (RT) on controlling brain metastasis (BM). The study suggested that a single dose of RT was effective in controlling small BM. Larger BM could be controlled more effectively with multiple rounds of RT. Some background The spread of cancer from the original tumor to other parts of the...

Controlling brain metastasis with localized radiotherapy.

Posted by Medivizor on Feb 17, 2021 in Lung cancer | 0 comments

In a nutshell This study evaluated the impact of radiotherapy (RT) on controlling brain metastasis (BM). The study suggested that a single dose of RT was effective in controlling small BM. Larger BM could be controlled more effectively with multiple rounds of RT. Some background The spread of cancer from the original tumor to other parts of the body...

Controlling brain metastasis with localized radiotherapy.

Posted by Medivizor on Feb 17, 2021 in Breast cancer | 0 comments

In a nutshell This study evaluated the impact of radiotherapy (RT) on controlling brain metastasis (BM). The study suggested that a single dose of RT was effective in controlling small BM. Larger BM could be controlled more effectively with multiple rounds of RT. Some background The spread of cancer from the original tumor to other parts of the body...

Looking for participants to test an experimental Keytruda-combination study treatment for Small Cell Neuroendocrine Prostate Cancer (SCNC)

Posted by Medivizor on Feb 15, 2021 in Prostate cancer | 0 comments

In a nutshell This clinical trial is evaluating the safety and effectiveness of an experimental treatment, BXCL701, in combination with pembrolizumab (Keytruda) for people with small cell neuroendocrine prostate cancer (SCNPCa). The main outcome to be measured will be the response rate to the study treatment. The details Prostate cancer is the...

Evaluating henagliflozin in patients with type 2 diabetes

Posted by Medivizor on Feb 14, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study tested the ability of henagliflozin (SHR3824) in controlling blood glucose levels in patients with type 2 diabetes (T2D). The authors found that henagliflozin alone was able to control glucose levels, reduce body weight and blood pressure in these patients. Some background Insulin is a hormone produced by the...

Evaluating the effectiveness of brentuximab vedotin and AVD chemotherapy combination in high-risk patients with advanced classical Hodgkin lymphoma

Adding S-1 to hormonal therapy in patients with ER+ HER2- breast cancer

Does anti-cancer therapy improve the outcomes of older patients with metastatic non-small cell lung cancer?

Long-term follow-up after bortezomib, thalidomide, and dexamethasone treatment followed by double stem cell transplant in patients with multiple myeloma.

Long term outcomes of nilotinib versus imatinib in chronic phase chronic myeloid leukemia

Is heart monitoring needed in patients with HER2-positive metastatic breast cancer using trastuzumab?

Controlling brain metastasis with localized radiotherapy.

Controlling brain metastasis with localized radiotherapy.

Controlling brain metastasis with localized radiotherapy.

Looking for participants to test an experimental Keytruda-combination study treatment for Small Cell Neuroendocrine Prostate Cancer (SCNC)

Evaluating henagliflozin in patients with type 2 diabetes

Categories

Recent Posts

Archives

Categories

Recent Posts

Archives

Thanks for your interest in Medivizor

Invalid email